Multiple Sclerosis
Interdisciplinary team, ‘loved-one standard’ can improve equitable access to palliative care
Advancing equitable access to palliative care will require interdisciplinary collaboration and effective communication, according to several leaders in the field.
Stem cell therapy improves mental, physical health in relapsing-remitting MS
Top-line results of a phase 2 clinical trial for an adiposederived autologous mesenchymal stem cell therapy to address mild to moderate relapsing-remitting MS found the treatment improved mental and physical health at 52 weeks.
No B-cell depletion found in children of mothers with MS treated with ocrelizumab
In pregnant women with MS given ocrelizumab, treatment did not result in infant B-cell depletion after birth, and the drug was virtually undetectable in the bloodstream of mother and child, according to a poster from ECTRIMS 2024.
Study: Sudden decrease in hospitalization rates were seen at start of COVID-19 pandemic
SAN DIEGO — Researchers reported a sudden decrease in all-cause hospitalization at the beginning of the COVID-19 pandemic, but there was an increase in all-cause mortality in patients on maintenance dialysis.
Data monitoring committee OKs continuation of phase 3 trial for vidofludimus calcium
An independent data monitoring committee has ruled that a phase 3 clinical trial investigating vidofludimus calcium for relapsing MS may continue as originally planned, according to the therapeutic’s manufacturer.
Diroximel fumarate linked to lower rate of severe infection in MS
Treatment with diroximel fumarate was linked to lower rates of severe infection compared with anti-CD20 monoclonal antibodies for adults of all ages with MS, according to a poster presented at ECTRIMS.
Early initiation of Kesimpta associated with lower rates of disability worsening in MS
Early initiation and continuation of Kesimpta in those with relapsing MS was associated with lower rates of disability worsening up to 6 years compared with those who switched medication, according to a presentation at ECTRIMS 2024.
MS linked to greater risk for certain cancers
People with MS had an increased risk for bladder, brain and cervical cancers compared with people without MS, according to a new study in Neurology, the medical journal of the American Academy of Neurology.
FDA grants investigational device exemption to vagus nerve stimulation system for MS
The FDA has granted investigational device exemption to a clinical-stage health care firm for its proprietary neuroimmune modulation platform for individuals with relapsing-remitting MS, according to the manufacturer.
Healio | Nephrology News & Issues adds new Editorial Advisory Board Members
Healio | Nephrology News & Issues recently added new members to its Editorial Advisory Board to expand its expertise in palliative care, pediatrics, vascular access, infection control and cardiorenal syndrome.